In this issue, you’ll meet activist Elizabeth Owens. Scroll down to click on her story and to see what else is inside.
Also Available On:
Elizabeth Owens was frightened when she learned she had hepatitis C, but advocacy and education are building up her courage.
The hep C treatment pipeline is starting to pick up at an increasing pace.
A California medical panel has lambasted Gilead Sciences for its exorbitant, $1,000-a-pill pricing of Sovaldi.
Just a few years ago, treatment options were bleak for people living with hepatitis C virus--especially those with advanced liver disease
Eighty-one percent of U.S. hepatitis C cases are among baby boomers.
New research has cast doubt on the presumed link between hep C and diabetes.
In April, a consortium of federal agencies updated the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis, originally draft...